![Benzo[a]pyrene](/ProductImageEN1/2024-11/Large/4151526e-2a9a-4796-b00b-30d8ee6b8781.png)
![Benzo[a]pyrene](/ProductImageEN1/2024-11/Small/4151526e-2a9a-4796-b00b-30d8ee6b8781.png)
Benzo[a]pyrene NEW
| Price | $35 | $73 | $123 |
| Package | 10mg | 25mg | 50mg |
| Min. Order: | |
| Supply Ability: | 10g |
| Update Time: | 2024-11-19 |
Product Details
| Product Name: Benzo[a]pyrene | CAS No.: 50-32-8 |
| Purity: ≥98% | Supply Ability: 10g |
| Release date: 2024/11/19 |
Product Introduction
Bioactivity
| Name | Benzo[a]pyrene |
| Description | Benzo[a]pyrene (3,4-Benzopyrene) shows lung carcinogenicity in mice in a dose-dependent manner. |
| Animal Research | After a 1- or 2-week acclimatization period, 360 adult male A/J mice and 520 adult female A/J mice were used for the experiment.?Mice were allocated, using a body weight-based randomization process, to a total of 22 groups.?Briefly, each animal received a single intraperitoneal administration of one of the initiators, at one of the indicated doses, on day 1.?The animals were observed daily for clinical signs and mortality, and body weights were measured weekly.?Following an overnight fast at 26 weeks after dosing, all mice were anesthetized with sevoflurane and weighed.?They were then sacrificed by exsanguination from the abdominal aorta and caudal vena cava and subjected to necropsy[1]. |
| In vivo | lung tumorigenesis induced by Benzo[a]pyrene(B[a]P) was dose dependent in female A/J mice.?The incidence of hyperplasia values in females treated with 0.25, 0.50, and 1.0 mg B[a]P were significantly higher than in the vehicle-treated group.?The incidence of adenoma in females receiving 1.0 mg B[a]P was significantly higher than in the vehicle group.?The multiplicity of hyperplasia in females receiving 0.50 or 1.0 mg B[a]P was significantly higher than in the vehicle group.?The multiplicity of adenoma in the group treated with 1.0 mg was also significantly higher than in the vehicle group.?The incidences of hyperplasia and adenoma in female A/J mice were significantly increased by B[a]P in a dose-dependent manner.?Proliferative lesions in the lungs were classified as bronchiolar-alveolar hyperplasia or adenoma, and no malignant neoplasms (adenocarcinoma) were observed[1]. |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
| Solubility Information | DMSO : 9.09 mg/mL (36.03 mM ), Sonication is recommended. |
| Keywords | Inhibitor | Endogenous Metabolite | inhibit | Benzo[a]pyrene |
| Related Compound Libraries | Bioactive Compound Library | Natural Product Library | Natural Product Library for HTS | Bioactive Compounds Library Max | Mouse Metabolite Compound Library | Human Metabolite Library |
Company Profile Introduction
Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers.
TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.
You may like
![5,6-Dimethyl-1H-benzo[d]imidazole](https://img.chemicalbook.com/ProductImageEN1/2024-11/Large/dfad330d-6467-403b-94ea-c1e52fb86efe.png)
Recommended supplier
| Product name | Price | Suppliers | Update time | |
|---|---|---|---|---|
| $15.00/1KG |
Zhuozhou Wenxi import and Export Co., Ltd
|
2021-07-10 | ||
| $/ |
Hebei Xibaijie Biotechnology Co., Ltd.
|
2020-07-10 | ||
| $1.00/1KG |
VIP7Y
|
Career Henan Chemical Co
|
2019-07-04 | |
| $15.00/1KG |
Zhuozhou Wenxi import and Export Co., Ltd
|
2021-07-09 |
United States- Since: 2011-01-07
- Address: 36?Washington?Street, Wellesley?Hills
INQUIRY